Cite
HARVARD Citation
Di Marco, V. et al. (2013). Who is more likely to respond to dual treatment with pegylated‐interferon and ribavirin for chronic hepatitis C? A gender‐oriented analysis. Journal of viral hepatitis. 20 (11), pp. 790-800. [Online].